Penson, Peter

Prevalence of statin intolerance: a meta-analysis

Bytyçi, I., Penson, P. E., Mikhailidis, D. P., Wong, N. D., Hernandez, A. V., Sahebkar, A., Thompson, P. D., Mazidi, M., Rysz, J., Pella, D., et al. (2022) · European Heart Journal

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 481

Inclisiran—New hope in the management of lipid disorders?

Dyrbuś, K., Gąsior, M., Penson, P., Ray, K. K., & Banach, M. (2020) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 120

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions

Penson, P. E., Mancini, G. B. J., Toth, P. P., Martin, S. S., Watts, G. F., Sahebkar, A., Mikhailidis, D. P., Banach, M., & on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) Group & International Lipid Expert Panel (ILEP) (2018) · Journal of Cachexia, Sarcopenia and Muscle

Pain Management and Placebo EffectLipoproteins and Cardiovascular Health

Cited by 110

Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis

Gjuladin-Hellon, T., Davies, I. G., Penson, P., & Amiri Baghbadorani, R. (2019) · Nutrition Reviews

Diet and metabolism studiesDietary Effects on Health

Cited by 108

Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go

Banach, M., & Penson, P. E. (2020) · JAMA Network Open

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 45

The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients

Bytyci, I., Bajraktari, G., Sahebkar, A., Penson, P. E., Rysz, R., & Banach, M. Y. (2021) · European Heart Journal

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 5